The drug was given either orally or through an IV. After 28 days, it had reduced deaths by 35% in patients who needed treatment with breath...

The annual sales value of these medicines has shrunk from nearly Rs 3,000 crore in 2016 to Rs 2,183 crore now.

The government challenged it in the top court on the ground that the ban was necessary in public interest, prompting the top court to stay ...

The company said there were no quality issues pertaining to the said two distinct component vaccine batches and that the recall was purely ...

The petition comes almost two months after the Delhi HC on December 2 set aside the govt notification that had banned hundreds of fixed dos...

The health ministry had on March 10 decided to ban 344 popular fixed dose combination (FDC) drugs, affecting nearly 6,000 brands, a move th...

The drug combination, known as PaMZ, killed more bacteria than standard treatment and was effective in treating drug-resistant tuberculosis.

Scientists have developed a new delivery system for a combination of two HIV drugs that may serve as an effective treatment for the deadly ...

Ranbaxy, which holds 180-day exclusivity for the generic version of the drug, was originally schedule to launch the drug in the US market i...

The country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...

The drug technical advisory board (DTAB) had put the drug under review due to complaints of side effects and approval without mandatory stu...

The pharma industry has opposed the drug controller general of India (DCGI) decision to include diclofenac-paracetamol combination-a non-st...

The rising demand for safe alternative medicine that has no side effects is leading to the growing demand in the segment. Work hard, sleep ...

Drug companies and the govt have formed separate technical committees to jointly decide which of the 294 combination drugs can be phased ou...

In a respite to pharma companies who have been asked to withdraw 294 combination drugs worth around Rs 3,500 crore.

Domestic drug makers will withdraw 120 combination drugs worth Rs 1000 crore, totalling over 270 brands from the market. Heavy drinking may...

Domestic pharma industry representative Indian Pharmaceutical Alliance (IPA) has asked the government to allow drug companies to sell fixed...